SF3B1 and myelodysplastic syndrome: Somatic SF3B1 mutations are found in approximately 30% of patients with myelodysplastic syndrome (MDS) and as many as 80% of patients with the MDS subtype characterized by ring sideroblasts (MDS-RS) [71].